{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T18:40:51Z","timestamp":1781116851619,"version":"3.54.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,3,25]],"date-time":"2016-03-25T00:00:00Z","timestamp":1458864000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Environ Biophys"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1007\/s00411-016-0647-4","type":"journal-article","created":{"date-parts":[[2016,3,25]],"date-time":"2016-03-25T06:26:33Z","timestamp":1458887193000},"page":"203-213","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Cytogenetic effects of radioiodine therapy: a 20-year follow-up study"],"prefix":"10.1007","volume":"55","author":[{"given":"Gordon K.","family":"Livingston","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3319-0109","authenticated-orcid":false,"given":"Igor K.","family":"Khvostunov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Gregoire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan-Francesc","family":"Barquinero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Tashiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,25]]},"reference":[{"issue":"4","key":"647_CR1","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/MNM.0b013e3283354c9e","volume":"31","author":"IN Asli","year":"2010","unstructured":"Asli IN, Mosaffa N, Mogharrabi M et al (2010) Chromosome aberrations after high-dose 131I and 99mTc-MIBI administration using a micronucleus assay. Nucl Med Commun 31(4):307\u2013310","journal-title":"Nucl Med Commun"},{"key":"647_CR2","first-page":"125","volume-title":"The causes and consequences of chromosomal aberrations, Chapter 5","author":"A Aurias","year":"1993","unstructured":"Aurias A (1993) Acquired chromosomal aberrations in normal individuals. In: Kirch IR (ed) The causes and consequences of chromosomal aberrations, Chapter 5. CRC Press, Boca Raton, pp 125\u2013140"},{"issue":"2","key":"647_CR3","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1269\/jrr.19.126","volume":"19","author":"AA Awa","year":"1978","unstructured":"Awa AA, Sofuni T, Honda T, Itoh M, Neriishi S, Otake M (1978) Relationship between the radiation dose and chromosome aberrations in atomic bomb survivors of Hiroshima and Nagasaki. J Radiat Res 19(2):126\u2013140","journal-title":"J Radiat Res"},{"issue":"6","key":"647_CR4","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/mutage\/gen040","volume":"23","author":"JM Battershill","year":"2008","unstructured":"Battershill JM, Burnett K, Bull S (2008) Factors affecting the incidence of genotoxicity biomarkers in peripheral blood lymphocytes: impact on design of biomonitoring studies. Mutagenesis 23(6):423\u2013437","journal-title":"Mutagenesis"},{"issue":"1","key":"647_CR5","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2307\/3571128","volume":"16","author":"MA Bender","year":"1962","unstructured":"Bender MA, Gooch PC (1962) Persistent chromosome aberrations in irradiated human subjects. Radiat Res 16(1):44\u201353","journal-title":"Radiat Res"},{"key":"647_CR6","first-page":"1317","volume-title":"Frontiers of thyroidology","author":"RS Benua","year":"1986","unstructured":"Benua RS, Leeper RD (1986) A method and rationale for treating thyroid carcinoma with the largest safe dose of I-131. In: Meideros-Neto GA, Gaitan E (eds) Frontiers of thyroidology, vol II. Plenum, New York, pp 1317\u20131321"},{"issue":"1","key":"647_CR7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/mutage\/geq075","volume":"26","author":"S Bonassi","year":"2011","unstructured":"Bonassi S, El-Zein R, Bolognesi C, Fenech M (2011) Micronuclei frequency in peripheral blood lymphocytes and cancer risk: evidence from human studies. Review. Mutagenesis 26(1):93\u2013100","journal-title":"Mutagenesis"},{"issue":"1","key":"647_CR8","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1667\/RR3558.1","volume":"166","author":"AB Brill","year":"2006","unstructured":"Brill AB, Stabin M, Bouville A, Ron E (2006) Normal organ radiation dosimetry and associated uncertainties in nuclear medicine, with emphasis on iodine-131. Radiat Res 166(1):128\u2013140","journal-title":"Radiat Res"},{"issue":"10","key":"647_CR9","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1097\/00043764-198610000-00037","volume":"28","author":"AV Carrano","year":"1986","unstructured":"Carrano AV (1986) Chromosomal alterations as markers of exposure and effect. J Occup Med 28(10):1112\u20131116","journal-title":"J Occup Med"},{"issue":"9","key":"647_CR10","first-page":"1549","volume":"45","author":"B Keizer de","year":"2004","unstructured":"de Keizer B, Hoekstra A, Konijnenberg MW et al (2004) Bone marrow dosimetry and safety of high 131-I activities given after recombinant human thyroid-stimulating hormone to treat metastatic differentiated thyroid cancer. J Nucl Med 45(9):1549\u20131554","journal-title":"J Nucl Med"},{"issue":"1","key":"647_CR11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0027-5107(93)90049-L","volume":"285","author":"M Fenech","year":"1993","unstructured":"Fenech M (1993) The cytokinesis-block micronucleus technique: a detailed description of the method and its application to genotoxicity studies in human populations. Mutat Res 285(1):35\u201344","journal-title":"Mutat Res"},{"issue":"1","key":"647_CR12","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0165-1161(85)90015-9","volume":"147","author":"M Fenech","year":"1985","unstructured":"Fenech M, Morley AA (1985) Measurement of micronuclei in lymphocytes. Mutat Res 147(1):29\u201336","journal-title":"Mutat Res"},{"key":"647_CR13","unstructured":"Gonzalez JA, Guimar\u00e3es MICC, Da Silva MA et al (2013) Dosimetry for patients with differentiated thyroid cancer in therapy with 131-I (NaI) preceded by rec-hTSH and establishment of a correlation between absorbed dose and cytogenetic effects of radiation in humans. In: IX Latin American IRPA regional congress on radiation protection and safety, IRPA 2013, Rio de Janeiro, Brazil, pp 1\u20136"},{"issue":"12","key":"647_CR14","first-page":"589","volume":"26","author":"S Guti\u00e9rrez","year":"1999","unstructured":"Guti\u00e9rrez S, Carbonell E, Galofr\u00e9 P, Creus A, Marcos R (1999) Cytogenetic damage after 131-iodine treatment for hyperthyroidism and thyroid cancer. A study using the micronucleus test. Eur J Nucl Med 26(12):589\u20131596","journal-title":"Eur J Nucl Med"},{"issue":"4","key":"647_CR15","first-page":"648","volume":"47","author":"H Haenscheid","year":"2006","unstructured":"Haenscheid H, Lassmann M, Luster M et al (2006) Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawal. J Nucl Med 47(4):648\u2013654","journal-title":"J Nucl Med"},{"issue":"2","key":"647_CR16","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0027-5107(98)00134-1","volume":"405","author":"L Hagmar","year":"1998","unstructured":"Hagmar L, Bonassi S, Str\u00f6mberg U et al (1998) Cancer predictive value of cytogenetic markers used in occupational health surveillance programs: a report from an ongoing study by the European study group on cytogenetic biomarkers and health. Mutat Res 405(2):171\u2013178","journal-title":"Mutat Res"},{"key":"647_CR17","unstructured":"IAEA Publication: Cytogenetic Dosimetry: Applications in Preparedness for and Response to Radiation Emergencies. Vienna: IAEA-EPR 2011"},{"issue":"2","key":"647_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.icrp.2004.08.003","volume":"34","author":"ICRP","year":"2004","unstructured":"ICRP (2004) Release of patients after therapy with unsealed radionuclides. ICRP Publication 94. Ann ICRP 34(2):1\u201379","journal-title":"Ann ICRP"},{"issue":"9","key":"647_CR19","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.radmeas.2011.05.011","volume":"46","author":"IK Khvostunov","year":"2011","unstructured":"Khvostunov IK, Sevan\u2019kaev AV, Lloyd DC, Nugis Yu, Voisin P (2011) Recent experience in applying the cytogenetic dosimetry assay. Radiat Meas 46(9):832\u2013836","journal-title":"Radiat Meas"},{"issue":"3","key":"647_CR20","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1269\/jrr.06086","volume":"48","author":"Y Kinashi","year":"2007","unstructured":"Kinashi Y, Sakurai Y, Masunaga S, Suzuki M, Nagata K, Ono K (2007) Evaluation of micronucleus induction in lymphocytes of patients following boron-neutron-capture-therapy: a comparison with thyroid cancer patients treated with radioiodine. J Radiat Res 48(3):197\u2013204","journal-title":"J Radiat Res"},{"issue":"2","key":"647_CR21","first-page":"35","volume":"73","author":"S Knehr","year":"1998","unstructured":"Knehr S, Zitzelsberger H, Bauchinger M (1998) FISH-based analysis of radiation-induced chromosomal aberrations using different nomenclature systems. Int J Radiat Biol 73(2):35\u2013141","journal-title":"Int J Radiat Biol"},{"issue":"4","key":"647_CR22","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1667\/0033-7587(2001)156[0337:SCAIAB]2.0.CO;2","volume":"156","author":"Y Kodama","year":"2001","unstructured":"Kodama Y, Pawel D, Nakamura N et al (2001) Stable chromosome aberrations in atomic bomb survivors: results from 25\u00a0years of investigation. Radiat Res 156(4):337\u2013346","journal-title":"Radiat Res"},{"issue":"2\u20133","key":"647_CR23","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1080\/15287399309531802","volume":"40","author":"GK Livingston","year":"1993","unstructured":"Livingston GK, Foster AF, Elson HR (1993) Effect of in vivo exposure to 131-iodine on the frequency and persistence of micronuclei in human lymphocytes. J Toxicol Environ Health 40(2\u20133):367\u2013375","journal-title":"J Toxicol Environ Health"},{"issue":"1","key":"647_CR24","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1667\/RR3586.1","volume":"166","author":"GK Livingston","year":"2006","unstructured":"Livingston GK, Falk RB, Schmid E (2006) Effect of occupational radiation exposures on chromosome aberration rates in former plutonium workers. Radiat Res 166(1):89\u201397","journal-title":"Radiat Res"},{"issue":"1","key":"647_CR25","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/09553009214551821","volume":"62","author":"JN Lucas","year":"1992","unstructured":"Lucas JN, Awa A, Straume T et al (1992) Rapid translocation frequency analysis in humans decades after exposure to ionizing radiation. Int J Radiat Biol 62(1):53\u201363","journal-title":"Int J Radiat Biol"},{"issue":"3","key":"647_CR26","first-page":"377","volume":"38","author":"R M\u2019Kacher","year":"1997","unstructured":"M\u2019Kacher R, Legal JD, Schlumberger M et al (1997) Sequential biological dosimetry after a single treatment with iodine-131 for differentiated thyroid carcinoma. J Nucl Med 38(3):377\u2013380","journal-title":"J Nucl Med"},{"issue":"5","key":"647_CR27","first-page":"825","volume":"39","author":"R M\u2019Kacher","year":"1998","unstructured":"M\u2019Kacher R, Schlumberger M, Legal JD et al (1998) Biologic dosimetry in thyroid cancer patients after repeated treatments with iodine-131. J Nucl Med 39(5):825\u2013829","journal-title":"J Nucl Med"},{"issue":"3","key":"647_CR28","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/mutage\/geu007","volume":"29","author":"F Maffei","year":"2014","unstructured":"Maffei F, Zolezzi-Moraga JM, Angelini S et al (2014) Micronucleus frequency in human peripheral blood lymphocytes as a biomarker for the early detection of colorectal cancer risk. Mutagenesis 29(3):221\u2013225","journal-title":"Mutagenesis"},{"issue":"9","key":"647_CR29","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1073\/pnas.92.9.3707","volume":"92","author":"AR Mclean","year":"1995","unstructured":"Mclean AR, Michie CA (1995) In vivo estimates of division and death rates of human T lymphocytes. Proc Natl Acad Sci USA 92(9):3707\u20133711","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"647_CR30","first-page":"1860","volume":"37","author":"R M\u2019Kacher","year":"1996","unstructured":"M\u2019Kacher R, Legal JD, Schlumberger M et al (1996) Biological dosimetry in patients treated with iodine-131 for differentiated thyroid carcinoma. J Nucl Med 37(11):1860\u20131864","journal-title":"J Nucl Med"},{"issue":"17","key":"647_CR31","doi-asserted-by":"crossref","first-page":"7474","DOI":"10.1073\/pnas.88.17.7474","volume":"88","author":"NE Morton","year":"1991","unstructured":"Morton NE (1991) Parameters of the human genome. Proc Natl Acad Sci USA 88(17):7474\u20137476","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"647_CR32","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/HP.0b013e3181c8f9ea","volume":"99","author":"AC Nascimento","year":"2010","unstructured":"Nascimento AC, Lipsztein JL, Corbo R, Rebelo AM (2010) 131-I biokinetics and cytogenetic dose estimates in ablation treatment of thyroid carcinoma. Health Phys 99(4):457\u2013463","journal-title":"Health Phys"},{"issue":"1","key":"647_CR33","first-page":"54","volume":"8","author":"L Popova","year":"2005","unstructured":"Popova L, Hadjidekova V, Hadjiev T, Agova S, Vasilev I (2005) Cytokinesis-block micronucleus test in patients undergoing radioiodine therapy for differentiated thyroid carcinoma. Hell J Nucl Med 8(1):54\u201357","journal-title":"Hell J Nucl Med"},{"issue":"1","key":"647_CR34","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/em.2850260105","volume":"26","author":"KL Radack","year":"1995","unstructured":"Radack KL, Pinney SM, Livingston GK (1995) Sources of variability in the human lymphocyte micronucleus assay: a population-based study. Environ Mol Mutagen 26(1):26\u201336","journal-title":"Environ Mol Mutagen"},{"issue":"1","key":"647_CR35","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1667\/RR3198","volume":"162","author":"P Rodr\u00edguez","year":"2004","unstructured":"Rodr\u00edguez P, Montoro A, Barquinero JF, Caball\u00edn MR, Villaescusa I, Barrios L (2004) Analysis of translocations in stable cells and their implications in retrospective biological dosimetry. Radiat Res 162(1):31\u201338","journal-title":"Radiat Res"},{"issue":"5","key":"647_CR36","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1089\/thy.2008.0392","volume":"19","author":"AM Sawka","year":"2009","unstructured":"Sawka AM, Thabane L, Parlea L et al (2009) Second primary malignancy risk after radioactive iodine treatment for thyroid cancer: a systematic review and meta-analysis. Thyroid 19(5):451\u2013457","journal-title":"Thyroid"},{"issue":"4","key":"647_CR37","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/rpd\/ncm444","volume":"129","author":"A Serna","year":"2008","unstructured":"Serna A, Alcaraz M, Navarro JL et al (2008) Biological dosimetry and Bayesian analysis of chromosomal damage in thyroid cancer patients. Radiat Prot Dosim 129(4):372\u2013380","journal-title":"Radiat Prot Dosim"},{"issue":"2","key":"647_CR38","first-page":"52","volume":"113","author":"AV Sevan\u2019kaev","year":"2005","unstructured":"Sevan\u2019kaev AV, Lloyd DC, Edwards AA, Khvostunov IK, Mikhailova GF, Golub EV, Shepel NN, Nadejina NM, Galstian IA, Nugis VY, Barrios L, Caballin MR, Barquinero JF (2005) A cytogenetic follow-up of some highly irradiated victims of the Chernobyl accident. Radiat Prot Dosim 113(2):52\u2013161","journal-title":"Radiat Prot Dosim"},{"issue":"5","key":"647_CR39","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1667\/RR2849.1","volume":"177","author":"L Shi","year":"2012","unstructured":"Shi L, Fujioka K, Sun J, Kinomura A, Inaba T, Ikura T, Ohtaki M, Yoshida M, Kodama Y, Livingston GK, Kamiya K, Tashiro S (2012) A modified system for analyzing ionizing radiation-induced chromosome abnormalities. Radiat Res 177(5):533\u2013538","journal-title":"Radiat Res"},{"issue":"2","key":"647_CR40","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.mrgentox.2008.01.005","volume":"652","author":"AJ Sigurdson","year":"2008","unstructured":"Sigurdson AJ, Ha M, Hauptmann M et al (2008) International study of factors affecting human chromosome translocations. Mutat Res 652(2):112\u2013121","journal-title":"Mutat Res"},{"issue":"1","key":"647_CR41","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/oxfordjournals.rpd.a033017","volume":"88","author":"I Sorokine-Durm","year":"2000","unstructured":"Sorokine-Durm I, Durand V, Delbos M, Le Baron L, Roy L, Voisin P (2000) A French view on FISH painting as a biodosimeter. Radiat Prot Dosim 88(1):35\u201344","journal-title":"Radiat Prot Dosim"},{"issue":"1","key":"647_CR42","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/mutage\/geq059","volume":"26","author":"Y Surowy","year":"2011","unstructured":"Surowy Y, Rinckleb A, Luedeke M et al (2011) Heritability of baseline and induced micronucleus frequencies. Review. Mutagenesis 26(1):111\u2013117","journal-title":"Mutagenesis"},{"issue":"1","key":"647_CR43","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0165-7992(95)90028-4","volume":"347","author":"JD Tucker","year":"1995","unstructured":"Tucker JD, Morgan WF, Awa AA et al (1995) PAINT: a proposed nomenclature for structural aberrations detected by whole chromosome painting. Mutat Res 347(1):21\u201324","journal-title":"Mutat Res"},{"key":"647_CR44","unstructured":"UNSCEAR Report (2001) Sources and effects of ionizing radiation. 2000 report to general assembly with annexes. Vienna: United Nations"},{"issue":"5","key":"647_CR45","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/mutage\/gel035","volume":"21","author":"D Varga","year":"2006","unstructured":"Varga D, Hoegel J, Maier C et al (2006) On the difference of micronucleus frequencies in peripheral blood lymphocytes between breast cancer patients and controls. Mutagenesis 21(5):313\u2013320","journal-title":"Mutagenesis"},{"issue":"2","key":"647_CR46","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1620\/tjem.229.115","volume":"229","author":"OB Vrndic","year":"2013","unstructured":"Vrndic OB, Milo\u0161evi\u0107-Djordjevi\u0107 OM, Mijatovi\u0107-Teodorovi\u0107 LC et al (2013) Correlation between micronuclei frequency in peripheral blood lymphocytes and retention of 131-I in thyroid cancer patients. Tohoku J Exp Med 229(2):115\u2013124","journal-title":"Tohoku J Exp Med"},{"issue":"3","key":"647_CR47","first-page":"436","volume":"39","author":"N Watanabe","year":"1998","unstructured":"Watanabe N, Yokoyama K, Kimuya S et al (1998) Radiosensitivity after iodine-131 therapy for thyroid cancer using the micronucleus assay. J Nucl Med 39(3):436\u2013444","journal-title":"J Nucl Med"},{"issue":"4","key":"647_CR48","first-page":"608","volume":"45","author":"N Watanabe","year":"2004","unstructured":"Watanabe N, Kanegane H, Kinuya S et al (2004) The radiotoxicity of 131-I therapy of thyroid cancer: assessment by micronucleus assay of lymphocytes. J Nucl Med 45(4):608\u2013611","journal-title":"J Nucl Med"}],"container-title":["Radiation and Environmental Biophysics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00411-016-0647-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00411-016-0647-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00411-016-0647-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T14:47:18Z","timestamp":1559054838000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00411-016-0647-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,25]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["647"],"URL":"https:\/\/doi.org\/10.1007\/s00411-016-0647-4","relation":{},"ISSN":["0301-634X","1432-2099"],"issn-type":[{"value":"0301-634X","type":"print"},{"value":"1432-2099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,25]]}}}